FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

13 results

ambien
(zolpidem tartrate)
Cosette Pharmaceuticals, Inc.
Usage: AMBIEN CR (zolpidem tartrate extended-release tablets) is indicated for the short-term treatment of insomnia, specifically for difficulties with sleep onset and maintenance. Efficacy was established in clinical trials lasting up to 24 weeks.
ambien
(zolpidem tartrate)
Cosette Pharmaceuticals, Inc.
Usage: AMBIEN (zolpidem tartrate) is indicated for the short-term treatment of insomnia, specifically to help with difficulties in initiating sleep. It has demonstrated effectiveness in reducing sleep latency for up to 35 days based on clinical studies.
doxepin hydrochloride
(Doxepin hydrochloride)
Novadoz Pharmaceuticals LLC
Usage: Doxepin tablets are indicated for treating insomnia with difficulty in sleep maintenance, supported by clinical trials lasting up to 3 months.
estazolam
(Estazolam)
Actavis Pharma, Inc.
Usage: Estazolam is indicated for the short-term management of insomnia, particularly for difficulties in falling asleep, nocturnal awakenings, and early morning awakenings. It is effective in improving sleep induction and maintenance, with evidence supporting its use for up to 12 weeks. Prolonged use is generally not recommended.
eszopiclone
(ESZOPICLONE)
Bionpharma Inc.
Usage: Eszopiclone tablets are indicated for the treatment of insomnia. They effectively decrease sleep latency and improve sleep maintenance, as shown in clinical trials lasting up to 6 months.
flurazepam hydrochloride
(Flurazepam Hydrochloride)
Chartwell RX, LLC
Usage: Flurazepam hydrochloride capsules are indicated for treating insomnia, including difficulty falling asleep, frequent awakenings, and early morning awakenings. Short-term use is generally recommended, as prolonged use should involve careful patient evaluation.
midazolam
(midazolam hydrochloride)
Sagent Pharmaceuticals
Usage: Midazolam Injection is indicated for preoperative sedation, anxiolysis, and amnesia; sedation for diagnostic and therapeutic procedures; induction of general anesthesia; and continuous infusion for sedation in intubated or mechanically ventilated patients in critical care settings.
ramelteon
(Ramelteon)
Westminster Pharmaceuticals, LLC
Usage: Ramelteon Tablets are indicated for treating insomnia characterized by difficulty with sleep onset. Efficacy was assessed in clinical trials lasting up to six months, focusing on sleep latency outcomes in both adults and the elderly.
ramelteon
(Ramelteon)
Micro Labs Limited
Usage: Ramelteon tablets are indicated for the treatment of insomnia, specifically for individuals experiencing difficulty with sleep onset. Clinical trials supporting its efficacy lasted up to six months.
rozerem
(ramelteon)
Takeda Pharmaceuticals America, Inc.
Usage: ROZEREM is indicated for the treatment of insomnia, specifically for individuals experiencing difficulty with sleep onset. Clinical trials supporting its efficacy lasted up to six months, assessing sleep latency at various intervals.

Medications for Sleep Initiation And Maintenance Disorders

ambien

ambien

doxepin hydrochloride

estazolam

eszopiclone

flurazepam hydrochloride

midazolam

ramelteon

ramelteon

rozerem